Zymergen

4 statements across 3 episodes · 1 bullish · 3 bearish · 2 people on the record · first statement Aug 6, 2021 by David Friedberg · said 22 times in 4 episodes since 2021 · across every show →

Mentions by year

brought up most by David Friedberg (15), Chamath Palihapitiya (4), David Sacks (2), Jason Calacanis (1)

tap a year for its mentions
0010220320212022episodesmentions
02320212022episodes it came up in
0031.56320212022episodesmentions per episode

every mention, scene by scene, with the transcript →

Everything said about Zymergen, oldest first

Aug 6, 2021 negative
Prediction Not checkable as stated
Friedberg: Zymergen's collapse will cause widespread skepticism in synthetic biology
“It's really going to impact the industry broadly, because now people are going to say a lot of synthetic biology companies are smoke and mirrors, and they're really not there yet.”
David Friedberg Aug 6, 2021 ▶ 36:55 E43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay & more
Aug 6, 2021 positive
Disclosure
David Sacks: Craft Ventures requires revenue before funding Series A rounds
“One of the reasons why we like SaaS and marketplace at Kraft is they're very milestone based. I mean, we, you know, if we invest before you have a functional product, it's going to be at a seed valuation, you know, like a 10 cap, ten million dollar valuation, …”
David Sacks Aug 6, 2021 ▶ 38:36 E43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay & more
Sep 18, 2021 negative
Assertion Supported
Friedberg: Zymergen raised $400M from SoftBank before disclosing zero revenue post-IPO
“Raised a four hundred million dollar round from SoftBank, took the company public. Then they go public, and a few weeks later, they're like, oh, wait, sorry, we don't actually have any product or any revenue.”
David Friedberg Sep 18, 2021 ▶ 1:10:24 E47: Facebook's week from hell, Ellen Pao on sexism in Elizabeth Holmes coverage, Newsom wins & more
Jul 29, 2022 negative
Assertion Supported
Friedberg: Zymergen sold for $300M after raising $1.5B
“Zymergen being acquired for three hundred million dollars comes off of them having raised a total of one and a half billion dollars of capital from many investors, including SoftBank and in their IPO, since they were founded in 2013.”
David Friedberg Jul 29, 2022 ▶ 1:10:45 E89: GDP growth negative in Q2, $SHOP layoffs, Alzheimer's fraud, Ginkgo acquires Zymergen & more
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.